Natco Pharma

BSE: 524816 | NSE: NATCOPHARM
Natco Pharma (CIN: L24230TG1981PLC003201) operates in the Pharmaceuticals industry and has been listed in the stock market since 11 Apr 1995. It currents trades on NSE with symbol NATCOPHARM and on BSE with scrip code 524816.
The registered office of the company is Natco House, Road No 2, Banjara Hills, Hyderabad, Telangana - 500033.

The management team of Natco Pharma is led by VENKAIAH CHOWDARY NANNAPANENI who is the Executive Director-Chairperson-MD. Other members of the management team consist of RAJEEV NANNAPANENI (Designation:Executive Director-CEO), SIVARAMAKRISHNA PRASAD POTLURI (Designation:Executive Director), LINGARAO DONTHINENI (Designation:Executive Director), AGNIHOTRA DAKSHINA MURTY CHAVALI (Designation:Non-Executive - Independent Director), DRONADULA VIJAYA BHASKAR (Designation:Non-Executive - Independent Director), LAKSHMINARAYANA BOLISETTY (Designation:Non-Executive - Independent Director), SUMA KANTIPUDI (Designation:Non-Executive - Independent Director), NITIN JAIN (Designation:Non-Executive - Independent Director), Amit Parekh (Designation:Chief Financial Officer), Chekuri Venkat Ramesh (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Natco Pharma is as below -

BSE 845 7.15 (0.85%)

BSE

845 7.15 (0.85%)
Volume: 72,324.00
M. Cap: 15,124.99
P/E: 13.21
Prev. Close: 840.00
52 Wk

NSE 1365 -35.3 (-2.52%)

NSE

1365 -35.3 (-2.52%)
Volume: 5,07,934.00
M. Cap: 15,111.56
P/E: 13.21
Prev. Close: 837.60
52 Wk

Stock Price Chart

F&O Data

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 8,85,15,126 49.42
Pledge 0 0.00
Foreign Institutions 3,11,15,988 17.37
Financial Institutions 97,01,512 5.42
NBFC and Mutual Funds 30,73,831 1.72
Others 4,97,77,244 27.78
Total 18,21,83,701 101.71

Financial Data

Consolidated
Figures in crore 2026 2025 2024
Net Sales 4,078.30 4,429.50 3,998.80
Operating Profit 1,734.10 2,550.50 1,879.50
Other Income 297.60 354.50 128.10
Interest 36.70 23.90 19.20
Depreciation 206.60 235.20 186.80
Profit Before Tax 1,490.80 2,291.40 1,673.50
Tax 118.90 408.00 285.20
Profit After Tax 1,371.90 1,883.40 1,388.30
Share Capital 35.80 35.80 35.80
Reserves 9,185.30 7,571.20 5,817.30
Net Worth 9,221.10 7,607.00 5,853.10
Loans 781.20 349.60 446.10
Gross Block 4,256.50 4,016.10 3,603.20
Investments 3,127.10 473.60 539.40
Cash 1,550.90 2,176.00 952.90
Debtors 881.20 1,246.60 1,188.90
Net Working Capital 3,778.80 4,564.90 3,131.70
Operating Profit Margin (%) 42.52 57.58 47.00
Net Profit Margin (%) 33.64 42.52 34.72
EPS 79.25 105.33 77.56
Dividend (%) 250.00 300.00 475.00
Dividend Payout 89.60 107.50 170.20
Standalone
Figures in crore 2026 2025 2024
Net Sales 3,594.60 4,094.50 3,568.90
Operating Profit 1,586.00 2,465.60 1,741.70
Other Income 281.10 321.30 104.70
Interest 32.30 19.60 14.50
Depreciation 189.60 220.00 171.90
Profit Before Tax 1,364.10 2,226.00 1,555.30
Tax 82.60 375.60 248.70
Profit After Tax 1,281.50 1,850.40 1,306.60
Share Capital 35.80 35.80 35.80
Reserves 8,516.80 7,298.10 5,556.50
Net Worth 8,552.60 7,333.90 5,592.30
Loans 776.60 344.80 441.00
Gross Block 3,993.90 3,783.70 3,359.50
Investments 3,264.90 855.10 741.70
Cash 1,187.30 1,856.90 864.90
Debtors 759.60 1,178.20 1,076.60
Net Working Capital 3,155.60 4,081.50 2,871.00
Operating Profit Margin (%) 44.12 60.22 48.80
Net Profit Margin (%) 35.65 45.19 36.61
Earning Per Share (Rs) 71.59 103.37 72.99
Dividend (%) 250.00 300.00 475.00
Dividend Payout 89.60 107.50 170.20
Dividend Declared (₹)
The company has declared dividend 5 times between 18 Feb 2025 and 20 Aug 2026, totaling Rs. 6.00 so far. The most recent dividend was declared on 20 Aug 2026 for Rs. 1.5.

Financial Data Graph

The peers of Natco Pharma are LUPIN, BIOCON and STAR. You can get more detailed information on those company by clicking on the respective names.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.